Form 3COAGCIK 0002114044
Hemab Therapeutics Holdings, Inc.
Initial insider ownership (Form 3) filed .
Initial statement of beneficial ownership filed by a company's officers, directors, and 10%+ owners when they first become an insider.
Filing facts
- Accession number
- 0001193125-26-198220
- Filer
- Hemab Therapeutics Holdings, Inc.
- Ticker
- COAG
- CIK
- 0002114044
- Form type
- Form 3
- Form description
- Initial insider ownership
- Filed at
- April 30, 2026
- Period of report
- April 30, 2026
- Industry
- SIC 2836Biological Products
- Filing size
- 31.5 KB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from Hemab Therapeutics Holdings, Inc.
See all 27 filings from Hemab Therapeutics Holdings, Inc. →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/2114044/000119312526198220/0001193125-26-198220-index.htm ↗Filer's full EDGAR submission history
EDGAR · Hemab Therapeutics Holdings, Inc. (0002114044) ↗SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.